FDA's Digital Health Advisory Committee weighs guardrails for generative AI in mental health devices
To address the risks associated with GenAI, FDA emphasized a number of safety-by-design principles including risk management strategies aligned with ...
Read the original at Hogan Lovells ↗
- Topics
- HealthcareChatbots & LLMsGovernance & Risk ManagementAI Safety & Existential Risk
- Mentions
- FDA
- Tracked via
- “AI Risks”
Same story, other outlets
- FDA's Digital Health Advisory Committee Weighs Guardrails for Generative AI in Mental ... JD Supra · Dec 20, 2025